Quadrant Capital Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-143	Closed	-$967	–	2831
2024 Q4	$967	Hold	143	–	–	﹤0.01%	2593
2024 Q3	$943	Buy	+143	New	+$943	﹤0.01%	2602